Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$15,489,884
+$485,913 QoQ
Shares Held
60,991
-0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.26%
of 13F equity value
Holder Rank
#867
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. JNJ ranks #1 (31.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,489,884 | 60,991 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $15,003,971 | 61,381 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $12,945,136 | 62,552 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $11,610,258 | 62,616 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $9,524,115 | 62,351 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,269,476 | 61,924 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,904,108 | 61,569 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $9,973,982 | 61,545 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $9,062,650 | 62,005 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $9,828,502 | 62,131 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $9,806,594 | 62,566 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $9,698,396 | 62,269 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $10,390,186 | 62,773 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,651,075 | 62,265 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $10,963,428 | 62,063 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,011,517 | 61,285 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $10,828,287 | 61,001 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $10,526,753 | 59,396 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $10,100,828 | 59,045 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $9,501,691 | 58,834 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $9,697,584 | 58,866 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $9,690,733 | 58,964 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,091,842 | 57,770 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $8,477,524 | 56,942 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $7,857,841 | 55,876 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $7,316,398 | 55,795 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||